scispace - formally typeset
Open AccessJournal ArticleDOI

DNA methylation age calculators reveal association with diabetic neuropathy in type 1 diabetes.

Delnaz Roshandel, +546 more
- 05 Apr 2020 - 
- Vol. 12, Iss: 1, pp 52
TLDR
Pan-tissue and GrimAge were higher whereas Skin & Blood and PhenoAge were lower than chronological age and DNAm age was not associated with the risk of CVD or retinopathy over 18–20 years after DNAm measurement.
Abstract
Many CpGs become hyper or hypo-methylated with age. Multiple methods have been developed by Horvath et al. to estimate DNA methylation (DNAm) age including Pan-tissue, Skin & Blood, PhenoAge, and GrimAge. Pan-tissue and Skin & Blood try to estimate chronological age in the normal population whereas PhenoAge and GrimAge use surrogate markers associated with mortality to estimate biological age and its departure from chronological age. Here, we applied Horvath’s four methods to calculate and compare DNAm age in 499 subjects with type 1 diabetes (T1D) from the Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications (DCCT/EDIC) study using DNAm data measured by Illumina EPIC array in the whole blood. Association of the four DNAm ages with development of diabetic complications including cardiovascular diseases (CVD), nephropathy, retinopathy, and neuropathy, and their risk factors were investigated. Pan-tissue and GrimAge were higher whereas Skin & Blood and PhenoAge were lower than chronological age (p < 0.0001). DNAm age was not associated with the risk of CVD or retinopathy over 18–20 years after DNAm measurement. However, higher PhenoAge (β = 0.023, p = 0.007) and GrimAge (β = 0.029, p = 0.002) were associated with higher albumin excretion rate (AER), an indicator of diabetic renal disease, measured over time. GrimAge was also associated with development of both diabetic peripheral neuropathy (OR = 1.07, p = 9.24E−3) and cardiovascular autonomic neuropathy (OR = 1.06, p = 0.011). Both HbA1c (β = 0.38, p = 0.026) and T1D duration (β = 0.01, p = 0.043) were associated with higher PhenoAge. Employment (β = − 1.99, p = 0.045) and leisure time (β = − 0.81, p = 0.022) physical activity were associated with lower Pan-tissue and Skin & Blood, respectively. BMI (β = 0.09, p = 0.048) and current smoking (β = 7.13, p = 9.03E−50) were positively associated with Skin & Blood and GrimAge, respectively. Blood pressure, lipid levels, pulse rate, and alcohol consumption were not associated with DNAm age regardless of the method used. Various methods of measuring DNAm age are sub-optimal in detecting people at higher risk of developing diabetic complications although some work better than the others.

read more

Citations
More filters
Journal ArticleDOI

Advanced glycation end products (AGEs) and other adducts in aging-related diseases and alcohol-mediated tissue injury.

TL;DR: In this article, a review of the properties of AGEs: their formation, accumulation, and receptor interactions, and their causative functions that impact various aging-related diseases.
Journal ArticleDOI

Understanding Diabetic Neuropathy: Focus on Oxidative Stress.

TL;DR: How the defects in metabolic and vascular pathways converge to enhance oxidative stress and how they produce the onset and progression of nerve injury present in diabetic neuropathy is discussed.
Journal ArticleDOI

Epigenetics of type 2 diabetes mellitus and weight change — a tool for precision medicine?

TL;DR: The role of epigenetic mechanisms in the development of type 2 diabetes mellitus and in the regulation of body weight in humans is discussed, with a special focus on precision medicine.
Journal ArticleDOI

Towards prevention of diabetic peripheral neuropathy: clinical presentation, pathogenesis, and new treatments

TL;DR: The pathophysiology of diabetic peripheral neuropathy (DPN) is complex, but mechanisms converge on a unifying theme of bioenergetic failure in the peripheral nerves due to their unique anatomy as mentioned in this paper .
References
More filters
Journal ArticleDOI

The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus.

TL;DR: Intensive therapy effectively delays the onset and slows the progression of diabetic retinopathy, nephropathy, and neuropathy in patients with IDDM.
Journal ArticleDOI

DNA methylation age of human tissues and cell types

TL;DR: It is proposed that DNA methylation age measures the cumulative effect of an epigenetic maintenance system, and can be used to address a host of questions in developmental biology, cancer and aging research.
Journal ArticleDOI

DNA methylation arrays as surrogate measures of cell mixture distribution

TL;DR: This work presents a method, similar to regression calibration, for inferring changes in the distribution of white blood cells between different subpopulations using DNA methylation signatures, in combination with a previously obtained external validation set consisting of signatures from purified leukocyte samples.
Related Papers (5)